3.2 Effect of use of ACEi/ARB in patients with COVID-19 on death (Figure 3)
There was a statistically significant 43% (95% CI: 0.37-0.88, I2=0.000) reduction in the odds of death in the patients on ACEi/ARB when compared to those not on ACEi/ARB. There was negligible heterogeneity.